|
Re: Published 8 days ago; review article out of Qatar Univ.
|
4
|
Resverlogix Corp.
|
Feb 16, 2024 08:07PM
|
|
Re: Proxy's
|
1
|
Resverlogix Corp.
|
Sep 28, 2019 08:46PM
|
|
Re: Proxy materials received in the US
|
1
|
Resverlogix Corp.
|
Aug 13, 2018 08:03PM
|
|
Re: Prostate Trial
|
6
|
Zenith Epigenetics
|
Apr 24, 2020 10:50AM
|
|
Re: Prospects for resverlogix
|
8
|
Resverlogix Corp.
|
Jul 15, 2020 12:21PM
|
|
Re: Properly powered? What does the FDA think?
|
|
Resverlogix Corp.
|
May 11, 2018 03:21AM
|
|
Re: Properly powered? What does the FDA think?
|
4
|
Resverlogix Corp.
|
May 11, 2018 04:46PM
|
|
Re: Progress
|
1
|
Resverlogix Corp.
|
Jul 28, 2020 07:49PM
|
|
Re: Progress
|
3
|
Resverlogix Corp.
|
Jul 25, 2020 11:25AM
|
|
Re: Probability of Phase 3 trial success
|
4
|
Resverlogix Corp.
|
Jun 24, 2019 12:07PM
|
|
Re: Private placement
|
6
|
Resverlogix Corp.
|
Aug 30, 2018 09:54AM
|
|
Re: Primary endpoint: Time vs Absolute Numbers
|
4
|
Resverlogix Corp.
|
Nov 19, 2018 01:39PM
|
|
Re: Priceless on I.V. Regarding Zenith
|
3
|
Zenith Epigenetics
|
Apr 09, 2017 01:08PM
|
|
Re: Price Spike
|
2
|
Resverlogix Corp.
|
Oct 29, 2021 04:12PM
|
|
Re: Price of ROFR for USA
|
2
|
Resverlogix Corp.
|
Feb 04, 2019 08:10AM
|
|
Re: Price boxed in....
|
5
|
Resverlogix Corp.
|
Jan 28, 2019 10:34AM
|
|
Re: Preview Part II....
|
4
|
Resverlogix Corp.
|
Mar 30, 2017 10:25PM
|
|
Re: Preview Part II....
|
3
|
Resverlogix Corp.
|
Mar 30, 2017 10:36PM
|
|
Re: Pretty quiet on the Zenith front,
|
4
|
Zenith Epigenetics
|
Aug 05, 2018 09:34PM
|
|
Re: Pretty much as expected
|
3
|
Resverlogix Corp.
|
Sep 17, 2019 03:03AM
|
